Investor Presentation • May 27, 2013
Investor Presentation
Open in ViewerOpens in native device viewer
May 2013
| d L a r g e a n i g r o w n g k t m a r e |
l d h h d h h h l b d h l d S i i i i t t t t t • w z e r a n a s e s e c o n g e s o s p a e c o v e r a g e n e w o r h l h d b f l S i i C H 6 1 1 % S i G F 5 D P t t t • w s s e a c a r e s p e n n g a p p r o x. n o r o o a w s s k h f C 3 % 0 % i 9 9 6 5 4 1 t t t t t • o n s a n m a r e g r o w o o p. a. s n c e |
|---|---|
| h G t r o w t p a r a m e e r s |
h l h d d l d i i i i i i i D t t • e m o g r a p c e v o u o n n c r e a s e s o r o p a e c a n o n c o o g c n c e n c e d h d d f h l h d l l‐ b i i i i P t t t • r o s p e r y r v e s e e m a n o r e a c a r e a n w e e n g s e r v c e s d f h l h d l l‐ b h l i i i i D t t t • e m a n o r e a c a r e a n e e n g s e r c e s a s p r o e n r e s e n o w v v l d h i i i i i i t e c o n o m c c c e s r n g e o n g o n g e c o n o m c c r s s y u b k h h f d A i i t t t t t t t t • o e a e r a e m a r e r o r a e s a r e e p e e o p e r s s n e r e v v g g w x c u u |
| k M t a r e t t s r u c u r e |
l d d d f h l d k l d d h S i i i i i t t t t • w z e r a n s r e g a r e a s o n e o e e a n g m a r e s w o r w e w d l f h l h i i t t t r e g a r s o q u a y o e a c a r e s e r v c e s f l h l d l 2 % S i i i i i i A 5 t t t t t • p p r o x. o o a w s s o s p a r e v e n u e s a r e g e n e r a e n p r v a e c n c s f f h l h ( ) i i i A 1 J 2 0 1 2, S H I A K V G t t t • s o a n a r a r e s o n o e s s e a n s r a n c e c a s u y v w u w d d l d h f f b d l l i i i i i i i t t t t n r o c e m p n g a p a r a g m s r o m e c a p a c o s p p p a n n n g u y y u y d d f l l d R i i i i i i i t t t t t t • e s o n s e p e c e o n c r e a s e c o m p e o n a n n a o r e c e c o s s. v x y u f f d l l d b f f h d i i i i i i i E t t t t t t c e n a n m a n a g e r a c n c s a r e e p e c e o e n e r o m s r e n x |
Long‐term commitment to operation's growth
Develop complementary healthcareservices
The board of directors of AEVIS combines financial, legal and political skills as well as in‐depth knowledge of the Swiss healthcaresector
Together, the board of directors and management of AEVIS cover the necessary skill set to address the challenges of AEVIS' scope of business
Together, the board of directors and the experienced management team of GSMN ensure an optimal development of AEVIS' mainparticipation
The board of directors of SHP is well aligned within the corporate governance of AEVIS and shares in‐depth knowledge of theportfolio of healthcare real estate
| l i i d b C G S M N n c s o w n e y |
i l b l A v a a e |
d i i A t t m n g |
l E m p o y e e s |
h i f O w n e r s p o |
|---|---|---|---|---|
| b d e s |
h i i p y s c a n s |
l t t r e a e s a e |
||
| l i i d l i C G n q u e e e n o e r |
1 1 5 |
1 7 7 |
2 9 0 |
S H P |
| k l k h i i i i P B t t r v a n e a n e n |
9 6 |
2 2 3 |
2 0 5 |
h d i T t r p a r y |
| l i i d i C A M n c a r s e c a |
7 5 |
3 0 |
1 8 0 |
S H P |
| l 'A C i i S t n c a a n n n a |
8 0 |
9 0 |
2 2 0 |
S H P |
| l é é l i i C G n q e n r a e u |
6 0 |
8 0 |
1 5 3 |
S H P |
| l i i d h i i C M t n q u e e o n c o s |
2 1 |
9 8 |
7 4 |
S H P |
| l l C i i V t n q u e a m o n |
5 7 |
4 | 0 0 1 |
S H P |
| é d i l d i C M E V t e n r e c a e s a u x‐ v e s |
/ n a |
2 1 |
3 0 |
G S M N P F |
| k l k b h P i i i O t r v a n a c |
6 5 |
4 5 |
1 2 0 |
S H P |
| k l k d b i i i i P L t r a n n e r g v |
7 3 |
9 5 |
1 6 2 |
S H P |
| l i i d l è C V n q u e e a r e |
4 0 |
5 0 |
2 0 0 |
S H P |
| ô l d l d i i H P t p a e a r o v e n c e |
6 5 |
2 5 |
3 0 5 |
h d i T t r p a r y |
| 1 i d P S y r a m e a m e e |
5 6 |
1 2 5 |
1 2 6 |
h d T i t r p a r y |
| l T t o a |
9 7 4 |
'0 6 3 1 |
'2 2 5 5 |
Affiliatedclinics Pyramide am See and Privatklinik Schwerzenbach
Healthcarerealestate
•
•
•
Genolier
CantonVaud
Zurich
CantonZurich
Lugano CantonTicino
| '0 I C H F 0 0 n |
2 0 1 2 |
2 H Y 2 0 1 2 |
1 H Y 2 0 1 2 |
2 0 1 1 |
|---|---|---|---|---|
| f i & K L P e y g u r e s |
||||
| l T t o a r e v e n u e |
'4 3 0 6 4 4 |
'6 8 2 0 3 1 |
'8 6 0 3 1 1 |
'8 2 0 0 8 1 |
| E B I T D A |
'9 3 9 6 8 |
'6 2 4 0 8 |
'3 1 5 6 0 |
'0 2 4 2 6 |
| i m a r g n |
1 1. 6 % |
1 3. 5 % |
9. 5 % |
1 1. 9 % |
| E B I T |
'7 6 1 4 1 |
'3 0 1 1 4 |
'4 3 5 7 |
'2 8 3 5 |
| i m a r g n |
% 4. 9 |
% 6. 2 |
% 3. 4 |
% 4. 1 |
| f i f h P t t r o o r e y e a r |
'3 3 2 5 |
'4 2 6 6 |
8 5 9 |
4 7 1 |
| f b l h i K t e y g u r e s a a n c e s e e |
||||
| l T t t o a a s s e s |
'4 7 3 4 4 8 |
'5 3 1 3 7 0 |
'8 1 7 6 8 3 |
|
| l l i b i l i i T t t o a a e s |
'9 5 7 2 0 8 |
'2 2 7 2 8 0 |
'0 1 4 3 3 6 |
|
| l i T t t o a e q u y |
'5 6 0 1 1 4 |
'2 9 0 4 1 |
'8 3 3 4 7 |
|
| i i t t e q r a o u y |
2 2 % |
1 3 % |
1 9 % |
* The 2HY2012figures include the results of Swiss Healthcare Properties AG, integrated on 2 July 2012.
| '0 In C H F 0 0 |
2 0 1 2 |
2 0 1 1 |
|---|---|---|
| l To ta r ev en ue h wt gro |
'4 3 4 4 0 6 17 2% |
'8 2 0 0 1 8 /a n |
| E B I T D A in ma rg |
'9 3 9 6 8 12 % |
'0 2 4 2 6 12 % |
| d ia io isa io De t t t p re c n an am or n |
'2 2 3 2 7 |
'7 1 3 5 7 |
| E B I T in ma rg |
'7 1 6 4 1 % 4.9 |
'2 8 5 3 % 4.1 |
| in ia l l F t an c r es u ha f lo f e i d S ty te re o ss o q u ac co un |
( '1 ) 8 5 8 |
( '0 ) 3 9 9 |
| inv te es es |
( '8 ) 2 4 9 |
( '2 ) 2 2 5 |
| d l Or in t ar y re su |
'7 5 3 4 |
'9 2 2 9 |
| d l Ex in tra t or ar y re su |
( '1 ) 1 8 5 |
( '6 ) 1 1 5 |
| be fo in Ea ta rn g s re xe s |
'2 3 5 4 |
'3 1 1 4 |
| In ta co m e xe s |
5 7 0 |
( ) 8 4 3 |
| f i fo he Pr t t o r ea r y in ma rg |
'3 3 2 5 1% |
4 7 1 0% |
| '0 In C H F 0 0 |
3 1. 1 2. 2 0 1 2 |
3 1. 1 2. 2 0 1 1 |
|---|---|---|
| f ig ba lan he Ke t y ur es ce s e |
||
| As ts se |
||
| l To ta t ts c ur re n a ss e |
'7 1 3 5 6 2 |
'0 7 6 2 8 |
| l To ta t a ts n on cu rre n ss e |
'6 5 9 8 8 6 |
'8 1 0 0 5 5 |
| l To ta ts a ss e |
'4 7 3 4 4 8 |
'8 1 7 6 8 3 |
| h wt gro |
41 5% |
/a n |
| b l L ia i i ie t s |
||
| l i To ta ty e q u |
'5 6 0 1 1 4 |
'8 3 3 4 7 |
| l l b l To ia i i ie ta t t c ur re n s |
'2 3 0 9 0 5 |
'5 1 0 3 1 0 |
| l l b l To ia i i ie ta t t n on ‐c ur re n s |
'7 2 6 3 0 3 |
'5 3 9 2 6 |
| l l b l ia i i ie To ta t s |
'9 2 0 8 5 7 |
'0 3 3 6 1 4 |
| l i d l ia b i l i ie To ta ty t e q an s u |
'4 7 3 4 4 8 |
'8 1 7 6 8 3 |
| h wt gro |
5% 41 |
/a n |
Shareprice performance January – December 2012 (Low: CHF 17.35 ‐ High: CHF 31)
| G S M N |
l h b l l d h i i N ‐t t t t t t • e w o n g e r m o u s o u r c n g c o n r a c s a v e e e n r e c e n y c o s e w l b d ( l b d l ) S i i D y n a a n o s m a a n c e a n n g h l b l d h i i i i i F t t t t • r e r p r o c e s s o p m s a o n s a r e c o n n o s e n g e p o r e s c a s u u u y x u d f l d f h i i i i t t r e g a r n g u n o r m a u n r y s e r v c e s o r e e n r e g r o u p f f h d b h h l h i i i i i i S t t t • e e e c s s c a s n c r e a s e a r g a n n g p o e r e a n s r e r s, z u w w u l l d h f l i i i i i i i t t t t t s p p e r s, e c. a r e m p e m e n e n e n e g r a o n p r o c e s s o n e c n c s u w |
|---|---|
| S H P |
's l‐ f l l d h S H P i i i t t t t t t • r e a e s a e p o r o o n c u e s m p o r a n g r o w r e s e r v e s l l b h l f l i i L i i i i i E t t t t • s p e c a y, n o u g a n o c n c s v a s s u r a c e e x p a n s o n p o e n a g v e s f l b l f h d l f l ' f f i i i i i i t t t e x y o r e e v e o p m e n o c n c s o e r n g s |
| h O t e r i t t n e s m e n s v |
l l b l b d d d d d N i i t t, t • e s c e n s w e e v e o p e a s a g r o u p w e r a n o s u p p o r c o n n e c a n l ' f f A E V I S i i t o m p e m e n s e r e o e r n s c v c g f ' h h h l d h O i A S G G E i i A E V I S i t t t t • e r n v e s m e n s s u c a s e p v e r s y p r e s e n c e n e f f h l h k d l l b l l d l i i i i i t t t t t t e a c a r e m a r e a n w e n e r o m a r g e c o n s o a o n p o e n a |
| i A t t t r a c v e f t s e c o r o c u s |
h f h d l h l h H i i i i i i t t t t t t t • g a r a c e n e s s o e g r o n g a n r e c e s s o n‐ r e s e n e a c a r e s e c o r v w h d ( l l d ) i D t t e m o g r a p c r e n s m o r e p e o p e g e o e r l h ( l h ) i i I t n c r e a s n g e c o n o m c w e a p e o p e a v e m o r e m o n e y l l f h l h ( l ) i i i i I t t n c r e a s n g w n g n e s s o p a y o r e a c a r e s e r v c e s p e o p e p a y m o r e |
|---|---|
| k M t a r e i i i t p o s o n n g |
d l l h b d h l S S i i i i i i t t t • e c o n a r g e s w s s p r v a e c n c s g r o u p w r o a g e o g r a p c a p r e s e n c e à‐ h l h d h S i i i i i i S i i i i t t t t t t t r o n g n e g o a o n p o s o n v s‐ v s w s s e a c a r e n s u r e r s a n a u o r e s d l l d l l h f k l d I i i i i i i t t t t t t t e a y p o s o n e o p a y a c v e r o e n e u u r e m a r e c o n s o a o n h d f l h h l C i i i i t t t t o p e w a n n u e n c e e c a n g n g r e g u a o r y e n v r o n m e n |
| d I t t n e g r a e b i s n e s s u l d m o e |
d b l h d d l d i i i i i S t t t t t t t • r o n g a n s a e c a s g e n e r a o n e o n e g r a e c n c o p e r a o n s a n u h l h l t t t e a c a r e r e a e s a e h f l b l f l f l d d H i i i i j i i t t t t t t • g e x y o r o n e v e o p m e n o o p e r a o n s a n r e a e s a e |
| L t o n g e r m ‐ b l i i t t s a y |
h b l f h f l d l d b H i i i i i i i t t t t • g v s y o c a s o w s u e o r e g u a e u s n e s s e n v r o n m e n b l h f l l h k l l S i i i i i t t t t t • a y n c a s o w p a n n n g a n s o o w o p e r a n g e v e r a g e l f h l h h S i i 2 0 % i i i A E V I E B I T D A t t t t t • e x p e c s o r e a s e a n m a r g n o m o r e a n n n e w e , d b h k i t n u s r y e n c m a r |
AEVIS Holding SA c/o Clinique Générale Ste‐Anne rue Hans‐Geiler 61700 Fribourg Tel. +41 26 350 02 02 Fax +4126 350 02 03
Media & Investor Relations c/o Dynamics Group Edwin van der Geest / Philippe Blangey Tel. +41 43 268 32 32 Fax +41 43 268 32 39 [email protected]
This communication contains statements that constitute "forward‐looking statements". In this communication, such forward‐looking statements include, without limitation, statements relating to our financial condition, results of operations and business and certain of our strategic plans and objectives. Because these forward‐looking statements are subject to risks and uncertainties, actual future results may differ materially from those expressed in or implied by the statements. Many of these risks and uncertainties relate to factors which are beyond AEVIS Holding's ability to control or estimate precisely, such as future market conditions, currency fluctuations, the behavior of other market participants, the actions of governmental regulators and other risk factors detailed in AEVIS Holding's past and future filings and reports and in past and future filings, press releases, reports and other information posted on AEVIS Group companies websites. Readers are cautioned not to put undue reliance on forward‐looking statements, which speak only of the date of this communication. AEVIS Holding disclaims any intention or obligation to update and revise any forward‐looking statements, whether as a result of new information, future eventsor otherwise.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.